Target Discovery and Validation Reviews and Protocols

Overview of Immune System 317
74. Dybwad, A., Bogen, A., Natvig, J. B., Førre, Ø., and Sioud, M. (1995) Peptide
phage libraries can be an efficient tool for identifying antibody ligands for polyclonal
antisera. Clin. Exp. Immunol. 102, 438–442.
75. Hansen, M. H., Østenstad, B., and Sioud, M. (2001) Antigen-specific IgG antibodies
in stage IV long-term survival breast cancer patients. Mol. Med. 7,
230–239.
76. Sioud, M. and Hansen, M. H. (2001) Profiling the immune response in patients
with breast cancer by phage-displayed cDNA libraries. Eur. J. Immunol. 31,
716–725.
77. Boublik, Y., Di Bonito, P., and Jones, I. M. (1995) Eukaryotic virus display: engineering
the major surface glycoprotein of the Autographa californica nuclear
polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus
surface. Biotechnology 13, 1079–1084.
78. Russel, S. J., Hawkins, R. E., and Winter, G. (1993) Retroviral vectors displaying
functional antibody fragments. Nucleic Acids Res. 21, 1081–1085.
79. Boder, E. T. and Wittrup, K. D. (1997) Yeast surface display for screening combinatorial
polypeptide libraries. Nat. Biotechnol. 15, 553–557.
80. Wadle, A., Mischo, A., Imig, J., et al. (2005) Serological identification of breast
cancer-related antigens from a Saccharomyces cerevisiae surface display library.
Int. J. Cancer 117, 104–113.
81. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. (1995) Serial analysis
of gene expression. Science 270, 484–487.
82. Lash, A. E., Tolstoshev, C. M., Wagner, L., et al. (2000) SAGEmap; a public gene
expression resource. Genome Res. 10, 1051–1060.
83. Boon, K., Osorio, E. C., Greenhut, S. F., et al. (2002) An anatomy of normal and
malignant gene expression. Proc Natl. Acad. Sci. USA 99, 11,287–11,292.
83a. Loging, W.T. et al. (2000) Identifying potential tumor markers and antigens by
database mining and rapid expression screening. Genome Res. 10, 1393–1402.
84. Segal, E., Fiedman, N., Kaminski, N., Regev, A., and Koller, D. (2005) From signatures
to models: understanding cancer using microarrays. Nat. Genet. 37,
S38–S45.
85. Leirdal, M., Shadidy, M., Røsok, Ø., and Sioud, M. (2004) Identification of genes
differentially expressed in breast cancer cell line SKBR3: Potential identification
of new prognostic biomarkers. Int. J. Mol. Med. 14, 217–222.
86. de Hoog, C. L. and Mann, M. (2004) Proteomics. Annu. Rev. Genomics Hum.
Genet. 5, 267–293.
87. Sioud, A. and Sørensen, D. (2003) Generation of an effective anti-tumor immunity
after immunization with xenogeneic antigens. Eur. J. Immunol. 33, 38–45.
88. Davis, I. D., Jefford, M., Parente, P., and Cebon, J. (2003) Rational approaches to
human cancer immunotherapy. J. Leukoc. Biol. 73, 3–29.
89. Zou, W. (2005) Immunosuppressive networks in the tumour environment and
their therapeutic relevance. Nat. Rev. 5, 263–274.
90. Sioud, M. (2004) Therapeutic siRNAs. Trends Pharmacol. Sci. 25, 22–28.